Bombesin Antagonists Inhibit Proangiogenic Factors in Human Experimental Breast Cancers

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6601404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

GnRH Antagonists in the Treatment of Gynecological and Breast Cancers

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2003English

Combination of GHRH Antagonists and Docetaxel Shows Experimental Effectiveness for the Treatment of Triple-Negative Breast Cancers

Oncology Reports
MedicineCancer ResearchOncology
2013English

Agonists of Growth Hormone-Releasing Hormone (GHRH) Inhibit Human Experimental Cancers in Vivo by Down-Regulating Receptors for GHRH

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Macrophages as Independent Prognostic Factors in Small T1 Breast Cancers

Oncology Reports
MedicineCancer ResearchOncology
2012English

The Levels of Circulating Proangiogenic Factors in Migraineurs

NeuroMolecular Medicine
Molecular NeuroscienceNeurologyMolecular MedicineCellular
2017English

Antagonists of Bombesin/Gastrin-Releasing Peptide as Adjuncts to Agonists of Luteinizing Hormone–releasing Hormone in the Treatment of Experimental Prostate Cancer

Cancer
Cancer ResearchOncology
1993English

Guanosine Nucleotides Inhibit Different Syndromes of PTHrP Excess Caused by Human Cancers in Vivo

Journal of Clinical Investigation
Medicine
2002English

The Expression Landscape of Cachexia‐inducing Factors in Human Cancers

Journal of Cachexia, Sarcopenia and Muscle
OrthopedicsSports MedicinePhysiology
2020English

Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy